meglumine antimoniate has been researched along with Bradyarrhythmia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sadeghi, M; Sadeghian, G; Ziaei, H | 1 |
| Abebe, Y; Abraham, Y; Ali, A; Berhe, N; Hailu, A; Mengistu, G; Tsige, K | 1 |
2 other study(ies) available for meglumine antimoniate and Bradyarrhythmia
| Article | Year |
|---|---|
Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic glucantime.
Topics: Administration, Oral; Adult; Animals; Antimony; Antiprotozoal Agents; Atrial Premature Complexes; Bradycardia; Bundle-Branch Block; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Prospective Studies; Ventricular Premature Complexes | 2008 |
Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis.
Topics: Adolescent; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Bradycardia; Child; Electrocardiography; Ethiopia; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2001 |